KIMBERLY HINDI: Open Payments
NPI 1043221161 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 27 payments from 13 companies in 2025. Trend: 2023 $1,184 · 2024 $1,156 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $119 |
| Amgen Inc. | 4 | $79 |
| ABBVIE INC. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Abbott Laboratories | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| PFIZER INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $28 |
| Exact Sciences Corporation | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $23 |
Products named: KRYSTEXXA, Ozempic, JARDIANCE, FREESTYLE LIBRE 3, Wegovy, UBRELVY, XIFAXAN, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
